MCCS publishes ‘broader’ cannabis prescription guidelines

The Medical Cannabis Clinicians’ Society (MCCS) and the All-Party Parliamentary Group (APPG) for Medical Cannabis under Prescription issued new guidance last week identifying conditions for which there are “conclusive or substantial”, “moderate”, and “limited” evidence of efficacy of medical cannabis treatment, as well as those for which it says there is “no conclusive evidence”. Mike […]

Continue Reading

Chief Medical Officer Dame Sally Davies complains cannabis medicine has ‘opened Pandora’s box’

Dame Sally Davies, England’s Chief Medical Officer, yesterday made the outrageous claim that “we know [THC] has an impact on the brain and causes depression, schizophrenia [and] brain development problems in young and adolescents” as she complained to the Health and Social Care Select Committee that the legalisation of cannabis medicine had “opened a Pandora’s […]

Continue Reading

Nathaniel Leahy: ‘Epidiolex has helped but he needs full extract cannabis oil’

The mother of 10-month-old Nathaniel Leahy has said that Epidiolex has had “some positive effects” on epilepsy but that full extract cannabis oil – which he is being denied – “could be the lifeline we need”. Whereas Epidiolex is CBD-based, full extract includes highly concentrated THC. As we reported recently, scientists in the US have […]

Continue Reading

De-schedule all cannabis say scientists who found THC is more therapeutic than CBD

Scientists who found THC to be more therapeutic than CBD in a groundbreaking study have called for all types of cannabis to be de-scheduled. “Despite the conventional wisdom, both in the popular press and much of the scientific community that only CBD has medical benefits while THC merely makes one high, our results suggest that […]

Continue Reading

Alzheimer’s Research UK announces ‘cannabis-based’ Sativex trial for dementia

The UK’s leading dementia research charity Alzheimer’s Research UK has announced it will fund a “pioneering” clinical trial at King’s College London using the “cannabis-based” treatment Sativex for people living with dementia. Sativex is a peppermint-flavoured mouth spray that contains a 1:1 ratio of two key cannabinoids found in the cannabis plant – delta-9-tetrahydrocannabinol (THC) […]

Continue Reading